ASH Annual Meeting 2025

位置: Orlando, Florida

日期:

活動詳細資訊:

Now in its 67th year, ASH remains the leading global forum for advances in classical and malignant hematology. With experience supporting 80+ blood disease clinical trials across all phases in APAC, North America, and Europe, Novotech brings deep regional expertise and global delivery capabilities to every hematology program. Our team will be on-site to discuss study planning and feasibility, regional start-up and regulatory strategies, site engagement, and data/biostatistics solutions—all designed to accelerate enrollment and streamline delivery for sponsors advancing hematology innovation.

Novotech Attendees:

  • Sarah Anderson — Director, Therapeutic Strategy
  • Pedro Rodriguez-Noriega — Associate Therapeutic Strategy Manager
  • Craig Leach — Associate Business Development Director

If you’d like to connect with our hematology team in Orlando, please request a meeting via the form on this page. 

本次活動已圓滿結束

誠摯感謝您在本次活動中對Novotech的關注。活動雖已落幕,但我們的專家團隊仍將持續為委託方提供全方位支援,協助推動各階段的臨床開發。

是否有任何疑問,或希望與我們進一步洽談?

歡迎諮詢臨床開發專家

攜手同行

Novotech

Sarah Anderson

Novotech
治療策略總監
Novotech

Pedro Rodriguez-Noriega

Novotech
治療策略副經理
Novotech

Craig Leach

Novotech
資深業務拓展經理